Quick Answer
Enveric Biosciences, Inc. reported Long Term Debt of $0.00 for the year ending 2018.
- Enveric Biosciences, Inc. showed a decrease of -100.0% in Long Term Debt from 2017 to 2018.
- This data is from Enveric Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2019.
- XBRL data for this metric is available from 2016 to 2018 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2015: $5.00 million | Q1 2016: $5.50 million | Q2 2016: $5.50 million | Q3 2016: $1.57 million | Q1 2017: $1.02 million | Q2 2017: $1.33 million | Q3 2017: $1.58 million | Q1 2018: $1.03 million | Q2 2018: $926.9 thousand | Q3 2018: $1.7 thousand.
- Over the full 3 years of available data (2016 to 2018), Enveric Biosciences, Inc.'s Long Term Debt has declined by 100.0%.
- Historical annual values: Fiscal year 2018: $0.00 | Fiscal year 2017: $1.13 million | Fiscal year 2016: $1.54 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: